BERG LLC is a leading biotechnology company based in Framingham, MA, specializing in the development of innovative diagnostic and therapeutic solutions for various diseases, including prostate health, breast cancer, pancreatic cancer, Parkinson's disease, and more. With a strong focus on clinical trials and medical research, BERG LLC aims to provide effective treatments and improved outcomes for patients suffering from conditions such as glioblastoma multiforme, epidermolysis bullosa, and chemotherapy-induced alopecia.
BPGbio, Inc., a subsidiary of BERG LLC, has acquired the assets of BERG LLC and holds licenses for the use of the Berg and Berg Health names. BPGbio, Inc. continues to advance the development of groundbreaking therapies, including their ongoing GBM Ph2 trial, as showcased in the SNO 2023 Poster presentation. Committed to delivering medical advancements, BPGbio, Inc. strives to enhance patient care and contribute to the field of biotechnology.
Generated from the website